EVE Ebit vs Cost Of Revenue Analysis

EVE Stock

0 0.00 0.00%

EVE Health financial indicator trend analysis is much more than just examining EVE Health Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EVE Health Group is a good investment. Please check the relationship between EVE Health Ebit and its Cost Of Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ebit vs Cost Of Revenue

Ebit vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EVE Health Group Ebit account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between EVE Health's Ebit and Cost Of Revenue is -0.34. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of EVE Health Group, assuming nothing else is changed. The correlation between historical values of EVE Health's Ebit and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of EVE Health Group are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebit i.e., EVE Health's Ebit and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.34

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ebit

Cost Of Revenue

Cost of Revenue is found on EVE Health Group income statement and represents the costs associated with goods and services EVE Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from EVE Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EVE Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 625.9 K in 2024. Discontinued Operations is likely to drop to about (2 M) in 2024

EVE Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment
Total Assets		0.35	-0.28	0.18	0.99	0.02	-0.48	0.41	0.66	0.52	0.95	0.49	0.39	0.62	0.6	0.03	-0.09	0.4	-0.21	0.23	0.43	-0.01	0.7	0.17	0.18	0.84
Short Long Term Debt Total	0.35		-0.74	-0.38	0.39	-0.61	-0.11	0.59	-0.15	0.12	0.49	0.08	0.97	0.19	-0.06	-0.49	-0.65	0.33	0.33	-0.17	-0.32	-0.52	0.52	0.67	0.65	0.52
Other Current Liab	-0.28	-0.74		0.61	-0.34	0.75	0.25	-0.77	0.31	-0.25	-0.4	0.03	-0.82	-0.3	-0.09	0.76	0.84	-0.34	-0.24	0.32	0.29	0.79	-0.35	-0.6	-0.59	-0.49
Total Current Liabilities	0.18	-0.38	0.61		0.06	0.85	0.17	-0.59	0.76	0.0	0.06	0.11	-0.43	-0.04	0.37	0.71	0.75	0.36	-0.38	0.9	0.36	0.71	0.11	-0.32	-0.3	-0.15
Total Stockholder Equity	0.99	0.39	-0.34	0.06		-0.09	-0.5	0.48	0.57	0.52	0.95	0.5	0.43	0.63	0.55	-0.05	-0.18	0.32	-0.16	0.1	0.4	-0.09	0.69	0.19	0.19	0.87
Other Liab	0.02	-0.61	0.75	0.85	-0.09		0.0	-0.82	0.67	0.15	-0.18	-0.2	-0.62	0.08	0.47	0.91	0.94	0.31	-0.67	0.77	0.57	0.91	-0.24	-0.28	-0.25	-0.42
Net Debt	-0.48	-0.11	0.25	0.17	-0.5	0.0		-0.02	-0.19	-0.97	-0.25	0.17	-0.19	-0.97	-0.55	-0.22	-0.09	-0.21	0.54	0.11	-0.79	-0.17	0.09	-0.22	-0.23	-0.2
Retained Earnings	0.41	0.59	-0.77	-0.59	0.48	-0.82	-0.02		-0.22	-0.04	0.61	0.51	0.61	0.06	-0.1	-0.88	-0.92	-0.04	0.54	-0.45	-0.45	-0.9	0.62	0.17	0.14	0.77
Accounts Payable	0.66	-0.15	0.31	0.76	0.57	0.67	-0.19	-0.22		0.34	0.53	0.36	-0.15	0.36	0.66	0.57	0.53	0.52	-0.51	0.74	0.55	0.55	0.34	-0.22	-0.19	0.35
Cash	0.52	0.12	-0.25	0.0	0.52	0.15	-0.97	-0.04	0.34		0.28	-0.22	0.2	0.99	0.67	0.29	0.17	0.44	-0.63	0.12	0.82	0.25	-0.02	0.28	0.29	0.17
Non Current Assets Total	0.95	0.49	-0.4	0.06	0.95	-0.18	-0.25	0.61	0.53	0.28		0.6	0.51	0.4	0.42	-0.21	-0.33	0.34	0.04	0.13	0.12	-0.24	0.83	0.2	0.2	0.94
Non Currrent Assets Other	0.49	0.08	0.03	0.11	0.5	-0.2	0.17	0.51	0.36	-0.22	0.6		0.05	-0.12	-0.07	-0.25	-0.26	-0.29	0.45	-0.04	-0.16	-0.24	0.64	-0.52	-0.53	0.71
Long Term Debt	0.39	0.97	-0.82	-0.43	0.43	-0.62	-0.19	0.61	-0.15	0.2	0.51	0.05		0.26	0.07	-0.51	-0.69	0.34	0.27	-0.2	-0.27	-0.54	0.48	0.7	0.68	0.53
Cash And Short Term Investments	0.62	0.19	-0.3	-0.04	0.63	0.08	-0.97	0.06	0.36	0.99	0.4	-0.12	0.26		0.67	0.23	0.1	0.42	-0.58	0.08	0.79	0.18	0.09	0.28	0.29	0.3
Net Receivables	0.6	-0.06	-0.09	0.37	0.55	0.47	-0.55	-0.1	0.66	0.67	0.42	-0.07	0.07	0.67		0.36	0.29	0.64	-0.71	0.51	0.67	0.31	0.13	0.19	0.2	0.19
Common Stock Total Equity	0.03	-0.49	0.76	0.71	-0.05	0.91	-0.22	-0.88	0.57	0.29	-0.21	-0.25	-0.51	0.23	0.36		0.96	0.15	-0.68	0.56	0.69	1.0	-0.32	-0.2	-0.17	-0.43
Common Stock Shares Outstanding	-0.09	-0.65	0.84	0.75	-0.18	0.94	-0.09	-0.92	0.53	0.17	-0.33	-0.26	-0.69	0.1	0.29	0.96		0.11	-0.64	0.59	0.64	0.97	-0.4	-0.32	-0.29	-0.52
Non Current Liabilities Total	0.4	0.33	-0.34	0.36	0.32	0.31	-0.21	-0.04	0.52	0.44	0.34	-0.29	0.34	0.42	0.64	0.15	0.11		-0.51	0.67	0.25	0.11	0.23	0.48	0.51	0.14
Other Stockholder Equity	-0.21	0.33	-0.24	-0.38	-0.16	-0.67	0.54	0.54	-0.51	-0.63	0.04	0.45	0.27	-0.58	-0.71	-0.68	-0.64	-0.51		-0.41	-0.78	-0.64	0.33	-0.05	-0.09	0.26
Total Liab	0.23	-0.17	0.32	0.9	0.1	0.77	0.11	-0.45	0.74	0.12	0.13	-0.04	-0.2	0.08	0.51	0.56	0.59	0.67	-0.41		0.31	0.55	0.22	-0.07	-0.04	-0.11
Total Current Assets	0.43	-0.32	0.29	0.36	0.4	0.57	-0.79	-0.45	0.55	0.82	0.12	-0.16	-0.27	0.79	0.67	0.69	0.64	0.25	-0.78	0.31		0.66	-0.18	-0.06	-0.04	-0.05
Common Stock	-0.01	-0.52	0.79	0.71	-0.09	0.91	-0.17	-0.9	0.55	0.25	-0.24	-0.24	-0.54	0.18	0.31	1.0	0.97	0.11	-0.64	0.55	0.66		-0.34	-0.23	-0.2	-0.45
Short Term Debt	0.7	0.52	-0.35	0.11	0.69	-0.24	0.09	0.62	0.34	-0.02	0.83	0.64	0.48	0.09	0.13	-0.32	-0.4	0.23	0.33	0.22	-0.18	-0.34		0.06	0.05	0.77
Property Plant And Equipment Net	0.17	0.67	-0.6	-0.32	0.19	-0.28	-0.22	0.17	-0.22	0.28	0.2	-0.52	0.7	0.28	0.19	-0.2	-0.32	0.48	-0.05	-0.07	-0.06	-0.23	0.06		1.0	0.11
Property Plant And Equipment Gross	0.18	0.65	-0.59	-0.3	0.19	-0.25	-0.23	0.14	-0.19	0.29	0.2	-0.53	0.68	0.29	0.2	-0.17	-0.29	0.51	-0.09	-0.04	-0.04	-0.2	0.05	1.0		0.11
Property Plant Equipment	0.84	0.52	-0.49	-0.15	0.87	-0.42	-0.2	0.77	0.35	0.17	0.94	0.71	0.53	0.3	0.19	-0.43	-0.52	0.14	0.26	-0.11	-0.05	-0.45	0.77	0.11	0.11

Click cells to compare fundamentals

EVE Health Account Relationship Matchups

EVE Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.1M	11.9M	8.1M	4.1M	2.5M	2.4M
Short Long Term Debt Total	584.3K	1.0M	492.4K	4.3K	74.9K	71.1K
Other Current Liab	131.2K	289.7K	309.0K	750.6K	959.4K	1.0M
Total Current Liabilities	581.8K	951.5K	743.1K	1.0M	1.3M	656.0K
Total Stockholder Equity	13.0M	10.2M	6.9M	3.1M	1.2M	1.2M
Net Debt	(4.6M)	(2.1M)	(610.0K)	(188.2K)	(31.3K)	(32.9K)
Retained Earnings	(20.3M)	(23.8M)	(29.1M)	(33.1M)	(34.8M)	(33.1M)
Accounts Payable	404.8K	431.5K	338.4K	254.2K	264.8K	295.4K
Cash	5.1M	3.2M	1.1M	192.5K	106.2K	100.9K
Non Current Assets Total	7.3M	7.2M	5.4M	13.2K	179.0	170.05
Non Currrent Assets Other	(217.5K)	(6.9M)	(6.9M)	(5.0M)	(13.2K)	0.0
Cash And Short Term Investments	5.1M	3.2M	1.1M	192.5K	106.2K	100.9K
Net Receivables	923.5K	352.4K	250.7K	115.7K	78.7K	74.8K
Common Stock Shares Outstanding	3.7B	4.6B	4.0B	5.2B	5.3B	5.5B
Liabilities And Stockholders Equity	14.1M	11.9M	8.1M	4.1M	2.5M	2.4M
Non Current Liabilities Total	76.8K	722.7K	538.5K	784.6K	396.6K	0.0
Other Stockholder Equity	(14.8M)	(12.0M)	(8.8M)	(5.0M)	(4.5M)	(4.7M)
Total Liab	1.1M	1.7M	1.1M	1.0M	1.3M	835.7K
Total Current Assets	6.8M	4.7M	2.7M	4.1M	2.5M	2.8M
Accumulated Other Comprehensive Income	297.5K	343.3K	415.3K	431.9K	194.0K	184.3K
Common Stock	33.0M	33.6M	35.6M	35.8M	41.2M	43.3M
Short Term Debt	45.8K	230.3K	95.7K	4.3K	74.9K	71.1K
Property Plant And Equipment Net	4.8M	5.2M	4.5M	13.2K	179.0	170.05
Property Plant And Equipment Gross	4.8M	5.7M	5.2M	26.5K	179.0	170.05
Property Plant Equipment	4.8M	5.2M	4.5M	11.1K	10.0K	9.5K
Other Current Assets	303.3K	202.6K	201.5K	3.3M	2.2M	2.3M
Inventory	766.6K	1.2M	1.4M	522.9K	141.5K	134.5K
Net Tangible Assets	12.0M	9.3M	6.8M	3.1M	3.6M	6.4M
Long Term Investments	1.8M	1.2M	701.0K	359.9K	323.9K	307.7K
Net Invested Capital	13.5M	10.7M	7.4M	4.6M	1.3M	1.2M
Cash And Equivalents	340.3K	5.1M	3.2M	1.1M	1.3M	1.2M
Net Working Capital	6.2M	3.7M	2.0M	4.1M	1.2M	1.2M
Current Deferred Revenue	(45.8K)	(230.3K)	(95.7K)	(1.0)	326K	342.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EVE Stock Analysis

When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC